US Stock MarketDetailed Quotes

IBRX ImmunityBio

Watchlist
  • 6.691
  • +0.331+5.21%
Trading Jul 8 10:52 ET
4.63BMarket Cap-6195P/E (TTM)

ImmunityBio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ImmunityBio Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

40.00K

-88.89%
EPS(YoY)

-0.20

+25.93%
Analyst Rating

Hold

Jun 30, 2024

ImmunityBio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.025M--
--2024/Q2-- / 2.525M--
--2024/Q140.000K / 25.000K--
--2023/Q4139.000K / 25.000K--
--2023/Q382.000K / 400.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 10.025M--
--2024/Q2-- / 2.525M--
--2024/Q140.000K / 25.000K--
--2023/Q4139.000K / 25.000K--
--2023/Q382.000K / 400.000K--

Unlock Free Earnings Estimates

ImmunityBio Earnings Reports

  • ImmunityBio | 10-Q: Quarterly report

    May 10 05:06

  • ImmunityBio | 10-K: Annual report

    Mar 20 04:39

  • ImmunityBio: Q3 2023 Earnings Report

    Nov 9, 2023 10:28

  • ImmunityBio | 10-Q: Q2 2023 Earnings Report

    Aug 9, 2023 04:15

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Hold

    • Buy

      0.00%

    • Hold

      100.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg